I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Long-term efficacy and safety of first-line ibrutinib treat..:
Burger, Jan A
;
Barr, Paul M
;
Robak, Tadeusz
...
qt8115t9n7. , 2020
Link:
https://escholarship.org/uc/item/8115t9n7
RT Journal T1
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study
UL https://suche.suub.uni-bremen.de/peid=base-ftcdlib:oai:escholarship.org:ark:_13030_qt8115t9n7&Exemplar=1&LAN=DE A1 Burger, Jan A A1 Barr, Paul M A1 Robak, Tadeusz A1 Owen, Carolyn A1 Ghia, Paolo A1 Tedeschi, Alessandra A1 Bairey, Osnat A1 Hillmen, Peter A1 Coutre, Steven E A1 Devereux, Stephen A1 Grosicki, Sebastian A1 McCarthy, Helen A1 Simpson, David A1 Offner, Fritz A1 Moreno, Carol A1 Dai, Sandra A1 Lal, Indu A1 Dean, James P A1 Kipps, Thomas J PB eScholarship, University of California YR 2020 K1 Rare Diseases K1 Clinical Research K1 Cancer K1 Clinical Trials and Supportive Activities K1 Lymphoma K1 Hematology K1 Genetics K1 Adenine K1 Aged K1 80 and over K1 Chlorambucil K1 Disease-Free Survival K1 Drug Administration Schedule K1 Female K1 Follow-Up Studies K1 Humans K1 Leukemia K1 Lymphocytic K1 Chronic K1 B-Cell K1 Male K1 Patient Safety K1 Piperidines K1 Prognosis K1 Progression-Free Survival K1 Pyrazoles K1 Pyrimidines K1 Risk K1 Treatment Outcome K1 Clinical Sciences K1 Oncology and Carcinogenesis K1 Immunology JF qt8115t9n7 LK http://dx.doi.org/https://escholarship.org/uc/item/8115t9n7 DO https://escholarship.org/uc/item/8115t9n7 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)